Tabetri® taheebo extract,
does it really help with Joint and cartilage health and knee discomfort?
research showsA 100-participant, 12-week trial of Tabetri at 600 mg/day was registered, but it was a single Jaseng Medical Foundation-sponsored study centered on subjective joint-pain and function outcomes, and no results were posted. Public efficacy data cannot be independently verified, supporting C with 42 points.
ads claimAmazonian tradition, cartilage protection, and arthritis improvement are often blended together. No public evidence establishes human cartilage preservation or slowed disease progression.
Useful facts when choosing a product
- It is Korean individually recognized ingredient 2022-2 with a recognized daily intake of 600 mg of Tabetri®.
- Korean finished products may combine it with vitamins, boswellia, or green-lipped mussel, which must be separated from single-ingredient evidence.
- The trial product is a standardized ethanolic inner-bark extract, not pau d'arco tea or unstandardized powder.
- Product labels advise caution in young children, pregnancy or lactation, allergy, and use of anticoagulants or immunosuppressants.
Chamgap Semantic Classification Code
Candidate index · review held
S.taheebo-extract.UNK.joint-and-cartilage-health-and-knee-discomfort.assess.placeboSupplements and nutraceuticals > Taheebo extract > Unknown > Joint and cartilage health and knee discomfort > Association or change assessment > Placebo
An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.
What the research actually shows
NCT03757611 tested Tabetri at 600 mg/day for 12 weeks in 100 participants at four Jaseng hospitals. Jaseng Medical Foundation was the sponsor, and the trial assessed subjective pain and function measures, but ClinicalTrials.gov reports no posted results. Park 2017 was an animal and cell study, not human efficacy evidence.
Why this is classified as C (42)
A single Jaseng-sponsored 100-participant trial used subjective outcomes, has no posted results, and lacks independent replication, supporting C with 42 points.
Counterpoint. A symptom signal may have been submitted to regulators, but public sources do not permit verification of effect size or primary-endpoint success.
Rejudgment record. Reassessment (cross-check reflected) — A single 100-participant Jaseng-sponsored trial used subjective outcomes, has no posted results, and lacks independent publication or replication
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Knee discomfort and function | C | A registered RCT exists, but public results and independent replication are lacking |
| Structural cartilage health | ? | No human cartilage-preservation evidence was identified |
Cross-check — AI research and Codex final gate
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| NCT03757611 | 12-week multicenter randomized double-blind placebo-controlled trial | 100 participants | Jaseng Medical Foundation; ingredient-related interests not publicly detailed | VAS, K-WOMAC, and KSF-36 | Completed, but no results were posted in the public registry. | Key; verification limited |
| Park et al. 2017 | MIA rat osteoarthritis and cell study | 10 rats per group plus cell models | Unverified; tested Tabetri® | Pain behavior, histology, and inflammatory mediators | Preclinical improvement signals, not human clinical outcomes. | Mechanistic support |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-07-17).
Final verification and publication gate: Codex · Evidence date: 2026-07-17 · Corrections: none
Cite this verdict
[Chamgap] Tabetri® taheebo extract x joint and cartilage health and knee discomfort — Evidence Grade C·42. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/joint-bone/tabetri-taheebo-joint-cartilage-knee/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.